We use cookies to offer you an optimal experience on our website. By browsing our website, you accept the use of cookies.

You must be logged in to watch this video. Click here to access your account, or here to register for free!

Hybrid surgical management of hilar cholangiocarcinoma

G Wakabayashi, MD, PhD, FACS
Epublication WebSurg.com, Oct 2013;13(10). URL: http://websurg.com/doi/lt03enwakabayashi003

Ask a question to the author

You must be logged in to ask a question to authors. Click here to access your account, or here to register for free!
  • 631
  • 5
  • 2013-10-14
Share it
Hilar cholangiocarcinoma (HC) is a rare tumor that causes devastating disease. Surgical margin-negative (R0) resection, including major liver resection, is the most effective and potentially curative treatment for HC. In this key lecture, Dr. Wakabayashi presents his surgical experience with the laparoscopic hybrid approach.